Last updated: July 12, 2026

Application No. 19/540,746

Untitled Application

Unknown

Filed

3900

Priority

May 18, 2018 — provisional 62/673,752 +5 more

Examiner

DIAMOND, ALAN D

Art Unit

3991

Tech Center

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Assignee

The Regents of the University of California

OA Round

1 (Non-Final)

Interview Optional

— +8.0% interview lift. Interview lift (+8.0%) is below the 15.0% threshold. A written response is recommended.

Based on 199 resolved cases, 2023–2026

Examiner Intelligence

DIAMOND, ALAN D View full profile →

Grants 71% — above average

Career Allowance Rate

142 granted / 199 resolved

+11.4% vs TC avg

Moderate +8% lift

Without

With

+8.0%

Interview Lift

resolved cases with interview

Typical timeline

2y 5m

Avg Prosecution

30 currently pending

Career history

229

Total Applications

across all art units

Statute-Specific Performance

§101

0.9%

-39.1% vs TC avg

§103

32.8%

-7.2% vs TC avg

§102

4.9%

-35.1% vs TC avg

§112

12.7%

-27.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 199 resolved cases

Prosecution Timeline

3900

Application Filed

Jul 07, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

16/751,032

Patent RE50942

Deuterated Compounds For Electronic Applications

6y 5m to grant Granted Jun 30, 2026

18/209,329

Patent RE50917

FORMULATIONS OF (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE

3y 0m to grant Granted Jun 16, 2026

18/118,955

Patent RE50875

PROCESSES FOR PRODUCING HIGH-PURITY TRIFLUOROIODOMETHANE

3y 1m to grant Granted Apr 28, 2026

17/969,338

Patent RE50811

Rapid Imaging Systems and Methods for Facilitating Rapid Radiation Therapies

3y 4m to grant Granted Mar 10, 2026

17/886,944

Patent RE50805

SINGLE-LAYER ORAL DOSE OF NEURO-ATTENUATING KETAMINE

3y 6m to grant Granted Feb 24, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

71%

Grant Probability

79%

With Interview (+8.0%)

2y 5m

Median Time to Grant

Low

PTA Risk

Based on 199 resolved cases by this examiner. Grant probability derived from career allowance rate.